Researchers have discovered Candida albicans can cross the blood–brain barrier, triggering an immune response that results in the formation of granuloma-type structures and memory impairments.
Browsing: Fungal Diseases
Researchers have successfully used monoclonal antibodies to protect animal models from Candida infections for the first time, demonstrating their potential for treating this fungal disease.
We look at some of the highlights of our Twitter chat (#TalkFungi), where we questioned Ilan Schwartz, Andrej Spec, Rebecca Drummond and Jessie Uehling about all things mycology.
Join us for our Twitter chat with experts in the field on the 2 October at 15:00 BST/ 10:00 EDT, discussing fungal diseases, their burden and the challenges that face them #TalkFungi.
In this interview, take a look behind the scenes of a recent Future Microbiology paper on the emergence of antifungal resistance and what can be done in response with author, Justin Beardsley.
In this interview, we speak to Ana Litvintseva, a Medical Mycologist and Team Lead at the Centers for Disease Control and Prevention (CDC; GA, USA) about Candida auris, its emergence and the challenges it presents.
Multi-use patient equipment, such as thermometers, has been linked to one of the largest outbreaks of the emerging drug-resistant fungal pathogen Candida auris to-date.
This study looks at Candida tropicalis, evaluating if radiation used in radiotherapy can cause changes in the virulence potential.
New drugs with antifungal action need to be developed. Here, the authors investigate the antifungal activity of MOL3, a small molecule that was selected by virtual screening, against Candida spp.
A novel CRISPR–Cas9-based gene drive platform has been developed by researchers and may help us understand some of the genetic networks underlying virulence in fungal pathogen, Candida albicans.